Updated 11 hours ago
Ozempic Kidney Trial Sinks Dialysis Stocks
Source: finance.yahoo.com
Related posts:
Palantir Stock Is Still Surging. It’s Not Just Earnings Causing Excitement.
AI chip giant Nvidia is about to report first-quarter earnings: Here’s what Wall Street expects as g...
Mobileye Stock Is Having Its Worst Day Ever. Its Revenue Forecast Was a Big Disappointment.
Just How Rich Do You Have to Be to Need Wealth Management?
Stock-Split Watch: 3 Red-Hot Tech Stocks That Could Split Their Shares in 2024